Sorrento Therapeutics Inc (SRNE)
0.015
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Sorrento Therapeutics Net Income (Quarterly): -95.21M for June 30, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -95.21M |
| March 31, 2023 | -139.62M |
| December 31, 2022 | -223.69M |
| September 30, 2022 | -89.58M |
| June 30, 2022 | -218.76M |
| March 31, 2022 | -40.82M |
| December 31, 2021 | -144.42M |
| September 30, 2021 | -119.80M |
| June 30, 2021 | -166.62M |
| March 31, 2021 | 2.51M |
| December 31, 2020 | -71.50M |
| September 30, 2020 | -84.02M |
| June 30, 2020 | -77.74M |
| March 31, 2020 | -65.20M |
| December 31, 2019 | -62.82M |
| September 30, 2019 | -64.42M |
| June 30, 2019 | -56.76M |
| March 31, 2019 | -108.07M |
| December 31, 2018 | -49.78M |
| September 30, 2018 | -47.33M |
| June 30, 2018 | -73.86M |
| March 31, 2018 | -32.57M |
| December 31, 2017 | 48.44M |
| September 30, 2017 | -2.061M |
| June 30, 2017 | -14.19M |
| Date | Value |
|---|---|
| March 31, 2017 | -23.06M |
| December 31, 2016 | -17.86M |
| September 30, 2016 | 15.89M |
| June 30, 2016 | -43.31M |
| March 31, 2016 | -15.65M |
| December 31, 2015 | -23.48M |
| September 30, 2015 | -0.939M |
| June 30, 2015 | -10.96M |
| March 31, 2015 | -10.44M |
| December 31, 2014 | -8.505M |
| September 30, 2014 | -7.605M |
| June 30, 2014 | -8.454M |
| March 31, 2014 | -10.09M |
| December 31, 2013 | -11.30M |
| September 30, 2013 | -3.356M |
| June 30, 2013 | -4.737M |
| March 31, 2013 | -2.522M |
| December 31, 2012 | -1.754M |
| September 30, 2012 | -1.241M |
| June 30, 2012 | -0.9431M |
| March 31, 2012 | -0.9061M |
| December 31, 2011 | -0.7621M |
| September 30, 2011 | -0.7023M |
| June 30, 2011 | -1.088M |
| March 31, 2011 | -0.6844M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-223.69M
Minimum
Dec 2022
2.51M
Maximum
Mar 2021
-101.09M
Average
-84.02M
Median
Sep 2020
Net Income (Quarterly) Benchmarks
| Scilex Holding Co | -21.40M |
| AIM ImmunoTech Inc | -12.58M |
| Perspective Therapeutics Inc | -24.68M |
| Protalix BioTherapeutics Inc | -6.044M |
| Armata Pharmaceuticals Inc | -19.85M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 15.02M |
| Total Expenses (Quarterly) | 91.79M |
| EPS Diluted (Quarterly) | -0.17 |
| Gross Profit Margin (Quarterly) | 43.74% |
| Profit Margin (Quarterly) | -633.7% |